[Antitumor activity of platinum analogs against human ovarian tumors heterotransplanted into nude mice].

The chemotherapeutic effects of CDDP, CBDCA and CHIP on human ovarian cancers heterotransplanted into nude mice (mucinous cystadenocarcinoma OVA-1, poorly differentiated adenocarcinoma OVA-2, endometrioid adenocarcinoma OVA-3, serous cystadenocarcinoma OVA-4, and three yolk sac tumors YST-1, YST-2, YST-3) were examined. OVA-1 did not respond to CDDP, although it responded well to CBDCA and CHIP. OVA-2 responded well to all these platinum analogs. OVA-3 responded well to CDDP, but did not respond to CBDCA or CHIP. OVA-4 responded well to CDDP and CBDCA, but did not respond to CHIP. Tumors YST-2 and YST-3 exhibited broadly comparable sensitivity to CDDP and the two other analogs, and YST-1 was substantially more sensitive to CDDP than to CBDCA or CHIP. The results indicated the necessity of selection of platinum analogs according to the histological types of tumor for the effective treatment of ovarian cancer.
AuthorsM Sawada, M Ozaki, J Hongo, Y Hirota, M Inagaki, H Taniguchi, R Tateishi, Y Mori
JournalGan to kagaku ryoho. Cancer & chemotherapy (Gan To Kagaku Ryoho) Vol. 14 Issue 3 Pt 1 Pg. 693-8 (Mar 1987) ISSN: 0385-0684 [Print] JAPAN
PMID3548596 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Organoplatinum Compounds
  • iproplatin
  • Carboplatin
  • Cisplatin
  • Animals
  • Antineoplastic Agents (administration & dosage, therapeutic use)
  • Body Weight (drug effects)
  • Carboplatin
  • Cisplatin (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Organoplatinum Compounds (administration & dosage, therapeutic use)
  • Ovarian Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: